GGrantIndex
Sort

78,016 grants matching breast cancer

An integrative approach to identify causal epigenetic markers for breast cancer

$493,991
Chunyan He · Indiana University Indianapolis · R01 · FY2016 · CA

Gasdermin E and pyroptosis in cancer

$493,985
Judy Lieberman · Boston Children'S Hospital · R01 · FY2022 · CA

Gasdermin E and pyroptosis in cancer

$493,985
Judy Lieberman · Boston Children'S Hospital · R01 · FY2023 · CA

West Virginia CoHORTS Center

$493,954
S. Suresh Madhavan · West Virginia University · R24 · FY2011 · HS

INTERACTIVE DECISION AID FOR BRCA 1/2 MUTATION CARRIERS

$493,927
Georgetown University · R01 · FY2003 · CA

Study of Break-induced Replication in Mammalian Cells

$493,922
Xiaohua Wu · Scripps Research Institute, The · R01 · FY2023 · CA

Study of Break-induced Replication in Mammalian Cells

$493,922
Xiaohua Wu · Scripps Research Institute, The · R01 · FY2022 · CA

Hypnosis to reduce aromatase inhibitor (AI)-associated musculoskeletal pain and to improve AI adherence: An RCT to explore clinical efficacy and cost effects

$493,903
Guy H Montgomery · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · AT

Macrophages as modulators of T cell function and therapeutic response in clear cell renal cell carcinoma

$493,861
Abraham Ari Hakimi · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA

RCT/Increase Colon Cancer Screening/Medicaid Managed Care

$493,838
Allen J. Dietrich · Dartmouth College · R01 · FY2008 · CA

PRETARGETING BACTERIAL THERAPY OF HER2+ BREAST CANCER

$493,829
The Johns Hopkins University · · FY2025 · Defense Health Agency

Breast Cancer Prevention by Letrozole in High Risk Women

$493,799
Carol J Fabian · University Of Kansas Medical Center · R01 · FY2007 · CA

Investigating the role of metabolic rewiring in breast tumor innervation

$493,795
Younghye Song · University Of Arkansas At Fayetteville · R37 · FY2025 · CA

A COVERTIBLE PET CAMERA FOR ONCOLOGY

$493,779
University Of Texas Md Anderson Can Ctr · R01 · FY2001 · CA

Care coordination for complex cancer survivors in an integrated safety-net system

$493,742
Simon J. Craddock Lee · Ut Southwestern Medical Center · R01 · FY2020 · CA

A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer

$493,712
Kristine L Kwekkeboom · University Of Wisconsin-Madison · R01 · FY2013 · NR

Role and Regulation of Id1 during Breast Cancer Metastasis Initiation

$493,705
Robert I Benezra · Sloan-Kettering Inst Can Research · P01 · FY2015 · CA

Novel Nanopolymers to Inhibit Angiogenesis and Increase the Anti-tumor Immunity

$493,702
Manuel L Penichet · University Of California Los Angeles · R01 · FY2012 · CA

Inhibitors of protein-protein interactions

$493,663
Nadya Tarasova · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

BREAST CANCER SURVIVORS: EXERCISE AND RALOXIFENE

$493,652
University Of Washington · R01 · FY2000 · NR

Disposition of Environmental Chemicals During Pregnancy

$493,634
Lauren M Aleksunes · Rutgers, The State Univ Of N.J. · R01 · FY2011 · ES

Targeting tumor-associated macrophages for triple-negative breast cancer treatment

$493,611
Mingye Feng · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA

Proteolysis-targeting chimera against BCL-XL inhibits breast cancer metastasis

$493,605
Weizhou Zhang · University Of Florida · R01 · FY2022 · CA

Rare Variant Associations With Severe Obesity in Utah Pedigrees

$493,597
Sandra J Hasstedt · University Of Utah · R01 · FY2014 · DK

Genetic and environmental interaction analyses and risk prediction modeling

$493,574
Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · U19 · FY2011 · CA